These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 15280683)

  • 1. Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.
    Höcker B; John U; Plank C; Wühl E; Weber LT; Misselwitz J; Rascher W; Mehls O; Tönshoff B
    Transplantation; 2004 Jul; 78(2):228-34. PubMed ID: 15280683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil.
    Höcker B; Weber LT; Feneberg R; Drube J; John U; Fehrenbach H; Pohl M; Zimmering M; Fründ S; Klaus G; Wühl E; Tönshoff B
    Transplantation; 2009 Mar; 87(6):934-41. PubMed ID: 19300199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen.
    Schnuelle P; van der Heide JH; Tegzess A; Verburgh CA; Paul LC; van der Woude FJ; de Fijter JW
    J Am Soc Nephrol; 2002 Feb; 13(2):536-543. PubMed ID: 11805185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid withdrawal in pediatric and adult renal transplant recipients.
    Tönshoff B; Höcker B; Weber LT
    Pediatr Nephrol; 2005 Mar; 20(3):409-17. PubMed ID: 15650883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients.
    Kim SJ; Lee KW; Lee DS; Lee HH; Lee SK; Kim B; Huh WS; Oh HY; Joh JW
    Transplant Proc; 2004 Sep; 36(7):2098-100. PubMed ID: 15518759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study.
    Abramowicz D; Del Carmen Rial M; Vitko S; del Castillo D; Manas D; Lao M; Gafner N; Wijngaard P;
    J Am Soc Nephrol; 2005 Jul; 16(7):2234-40. PubMed ID: 15917338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results.
    Rama I; Cruzado JM; Gil-Vernet S; Torras J; Serón D; Castelao AM; Ibernón M; Bestard O; Grinyó JM
    Transplantation; 2005 Jul; 80(2):164-8. PubMed ID: 16041259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients.
    Grinyo JM; Gil-Vernet S; Serón D; Cruzado JM; Moreso F; Fulladosa X; Castelao AM; Torras J; Hooftman L; Alsina J
    Transplantation; 1997 Jun; 63(11):1688-90. PubMed ID: 9197368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
    Ahsan N; Hricik D; Matas A; Rose S; Tomlanovich S; Wilkinson A; Ewell M; McIntosh M; Stablein D; Hodge E
    Transplantation; 1999 Dec; 68(12):1865-74. PubMed ID: 10628766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid withdrawal and reduction of cyclosporine A under mycophenolate mofetil after heart transplantation.
    Faulhaber M; Mäding I; Malehsa D; Raggi MC; Haverich A; Bara CL
    Int Immunopharmacol; 2013 Apr; 15(4):712-7. PubMed ID: 23454241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.
    Le Meur Y; Thierry A; Glowacki F; Rerolle JP; Garrigue V; Ouali N; Heng AE; Delahousse M; Albano L; Lang P; Couzi L; Jaureguy M; Lebranchu Y; Mousson C; Glotz D; Kessler M; Vrtovsnik F; Rouanet S; Tagieva N; Kamar N
    Transplantation; 2011 Dec; 92(11):1244-51. PubMed ID: 22067312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E
    Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation.
    Höcker B; Weber LT; Feneberg R; Drube J; John U; Fehrenbach H; Pohl M; Zimmering M; Fründ S; Klaus G; Wühl E; Tönshoff B
    Nephrol Dial Transplant; 2010 Feb; 25(2):617-24. PubMed ID: 19793929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early steroid withdrawal in pediatric renal transplantation at a single center: preliminary report.
    Valenzuela M; Delucchi A; Ferrario M; Lillo AM; Guerrero JL; Rodríguez E; Cano F; Cavada G
    Transplant Proc; 2008 Nov; 40(9):3237-40. PubMed ID: 19010242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.
    Offner G; Toenshoff B; Höcker B; Krauss M; Bulla M; Cochat P; Fehrenbach H; Fischer W; Foulard M; Hoppe B; Hoyer PF; Jungraithmayr TC; Klaus G; Latta K; Leichter H; Mihatsch MJ; Misselwitz J; Montoya C; Müller-Wiefel DE; Neuhaus TJ; Pape L; Querfeld U; Plank C; Schwarke D; Wygoda S; Zimmerhackl LB
    Transplantation; 2008 Nov; 86(9):1241-8. PubMed ID: 19005406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine.
    Pelletier RP; Akin B; Ferguson RM
    Clin Transplant; 2006; 20(1):10-8. PubMed ID: 16556147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.